Teva Pharmaceutical Industries News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

28.03.08	Barr Announces Reorganization of Senior Management, Business Functions (PR Newswire)
25.02.08	Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA (PR Newswire)
21.02.08	AmniScreen(TM) Amniotic Fluid Detection Device is Now Available (PR Newswire)
19.02.08	Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg (PR Newswire)
02.11.07	Barr Confirms Patent Challenge of Ritalin(R) LA (PR Newswire)
30.10.07	Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg (PR Newswire)
24.10.07	Virtual Reality: Der nächste Schritt für Advertiser (Businesswire)
23.10.07	Bentley Pharmaceuticals, Inc. Announces Plans to Separate Its Two Businesses and Explore Strategic Alternatives with Respect to Its Generics Business (Businesswire)
31.10.06	PLIVA Announces Changes in Management and Supervisory Boards (PR Newswire)
20.10.06	Barr Acquires PLIVA d.d. Following Official Closing of Tender Offer Process (PR Newswire)
11.09.06	Bentley Pharmaceuticals Names Richard P. Lindsay Vice President and CFO (PR Newswire)
31.08.06	Barr Evaluating Actavis Group's Competing Bid for PLIVA d.d. (PR Newswire)
28.07.06	Barr Files Formal Tender Offer for PLIVA d.d. With HANFA (PR Newswire)
10.01.06	Barr Names G. Frederick Wilkinson President and COO of Duramed Pharmaceuticals, Inc. (PR Newswire)
12.12.05	Bentley Pharmaceuticals Announces the Marketing Approval of Lansoprazole in the UK; December 12, 2005 Launch is Scheduled Through Its Licensees (Businesswire)
28.09.05	Barr Confirms Patent Challenge of Mirapex(R) (PR Newswire)
04.05.05	Bentley Pharmaceuticals Reports 40% Increase in First Quarter 2005 Rev (Businesswire)
28.04.05	Bentley Pharmaceuticals Receives Approval to Market Generic Versions o (Businesswire)
25.04.05	Bentley Pharmaceuticals and Dong Sung Pharmaceuticals Enter into a Lic (Businesswire)
21.04.05	Bentley Pharmaceuticals, Inc. to Present Results of Initial Phase II I (Businesswire)
08.03.05	Bentley Pharmaceuticals Reports Fiscal 2004 Revenues of $73.4 Million (Businesswire)
04.03.05	Bentley Pharmaceuticals to Release Fourth Quarter and Year End 2004 Fi (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

30.01.24		Ausblick: Teva Pharmaceutical Industries legt die Bilanz zum abgelaufenen Quartal vor
09.05.23		Ausblick: Teva Pharmaceutical Industries stellt das Zahlenwerk zum vergangenen Quartal vor
07.02.23		Ausblick: Teva Pharmaceutical Industries stellt Ergebnisse des abgelaufenen Quartals vor
02.11.22		Ausblick: Teva Pharmaceutical Industries öffnet die Bücher zum abgelaufenen Quartal
25.10.21		Ausblick: Teva Pharmaceutical Industries zieht Bilanz zum abgelaufenen Quartal
12.02.19		Ausblick: Teva Pharmaceutical Industries präsentiert Quartalsergebnisse